Archive: Harm Reduction Programs May Prevent Hepatitis C in Injection Drug Users
Researchers at UCSF and their colleagues have found that Hepatitis C virus (HCV) infection among people who inject drugs remains high and stable in some North American cities but incidence has dropped and remained low in some Australian and European cities.